What is being built?

KÉSZ Csoport builds our country's latest pharmaceutical investment

Published

The handover ceremony, source: Facebook / CevaPhylaxiaCampus
The new CEVA-PHYLAXIA plant is built in Monor.

The general contractor company KÉSZ Csoport, KÉSZ Építő Zrt., has won the EPC (Engineering, Procurement and Construction) project for the expansion of the Ceva-Phylaxia Oltóanyagtermelő Zrt. Monor site, according to a statement sent to our newspaper.

Ceva is the 5th largest animal health company in the world, currently producing 70 billion doses of vaccines per year in Hungary, which is expected to increase to 80 billion doses after the developments. In parallel, the creation of 120 new jobs will strengthen the economic competitiveness of the region in the coming years.

State-of-the-art technologies on 7000 square metres

The new plant, which is currently under construction, will produce multicomponent inactivated vaccines and fermented antigens for animals to prevent various infectious diseases. The investment contract was signed on 11 November 2024 between Ceva and KÉSZ Építő Zrt., with a preliminary estimated value of €40 million and an expected duration of 2 years.

According to a statement by László Huszti, a member of the board of directors of KÉSZ Építő Zrt.:

"For KÉSZ Csoport, investments which, in addition to their domestic importance, will later strengthen the position of the company in regional and international terms are of particular importance. Our client Ceva-Phylaxia will be able to further increase its international presence in the veterinary market with its new production facilities, supplying vaccines from its Hungarian production facility to all parts of the world. Professionally, it will strengthen our group's experience in a new industry, which is always an exciting challenge for us."

Traditional and innovative solutions in construction

In addition to traditional documentation, the experts involved in the project compiled both the design and construction costs based on the BIM model. This is a truly fitting challenge for KÉSZ Építő Zrt. in terms of the structure of the project, as it already has extensive experience in tasks ranging from piling and prefabricated reinforced concrete structures to cladding, sandwich panels, and the construction of roads and utilities for the building. Several member companies and strategic partners of the group will also be involved in the construction, including bim.GROUP in the design and and in construction by DVB and the industrial flooring team of KÉSZ Építő.

The investment aims to increase the factory capacity of the existing Ceva-Phylaxia Oltóanyagtermelő Zrt. Monor Csévharaszti road site by building a new factory building (MFF) and an associated power building (CUB). The greenfield investment will include 2 new buildings with clean rooms of category "B-C-D" and "BSL2", where antigen production technology will be transferred to the new production area to increase production capacity.

Work on the project began on 14 November with a kick-off meeting for the designers and a ceremonial groundbreaking ceremony, which we reported on in our newspaper.

The laying of the foundation stone was attended by Jonathan Lacôte, Ambassador-designate of France to Hungary, Dr. Boglárka Illés, Secretary of State for Foreign Affairs, Dr. Véronique Kodjo, Executive Vice President of Ceva, Dr. Tamás Szamkó, CEO of Ceva in Hungary, Gergely Karbuczky, Deputy Chief Operating Officer of HIPA, Kálmán Darázsi, Mayor of Monor and Tibor Pogácsás, State Secretary and Member of the Parliament of the region.

Source : Link

Popular